| Primary |
| Atrial Fibrillation |
53.1% |
| Arrhythmia |
10.2% |
| Heart Rate Irregular |
6.8% |
| Ventricular Fibrillation |
5.4% |
| Ventricular Tachycardia |
4.8% |
| Cardiac Fibrillation |
2.7% |
| Drug Use For Unknown Indication |
2.7% |
| Ventricular Extrasystoles |
2.7% |
| Cardiac Disorder |
2.0% |
| Atrial Flutter |
1.4% |
| Cardiac Ablation |
1.4% |
| Ventricular Arrhythmia |
1.4% |
| Blood Cholesterol |
0.7% |
| Blood Cholesterol Increased |
0.7% |
| Blood Pressure |
0.7% |
| Cardiac Failure Congestive |
0.7% |
| Cardiac Operation |
0.7% |
| Cardioversion |
0.7% |
| Chest Pain |
0.7% |
| Heart Rate Increased |
0.7% |
|
| Tremor |
12.7% |
| Dyspnoea |
9.1% |
| Pulmonary Fibrosis |
9.1% |
| Pulmonary Toxicity |
9.1% |
| Blindness |
5.5% |
| Optic Neuropathy |
5.5% |
| Visual Field Defect |
5.5% |
| Vomiting |
5.5% |
| Weight Decreased |
5.5% |
| Myalgia |
3.6% |
| Photosensitivity Reaction |
3.6% |
| Respiratory Distress |
3.6% |
| Respiratory Failure |
3.6% |
| Speech Disorder |
3.6% |
| Visual Impairment |
3.6% |
| Wheezing |
3.6% |
| Alopecia |
1.8% |
| Asthenia |
1.8% |
| Blindness Transient |
1.8% |
| Blood Pressure Increased |
1.8% |
|
| Secondary |
| Atrial Fibrillation |
29.9% |
| Ventricular Fibrillation |
17.4% |
| Product Used For Unknown Indication |
10.2% |
| Arrhythmia |
9.0% |
| Drug Use For Unknown Indication |
8.4% |
| Heart Rate Irregular |
4.2% |
| Ill-defined Disorder |
3.6% |
| Blood Cholesterol Increased |
1.8% |
| Cardiac Fibrillation |
1.8% |
| Ventricular Extrasystoles |
1.8% |
| Ventricular Tachycardia |
1.8% |
| Wound Treatment |
1.8% |
| Anticoagulant Therapy |
1.2% |
| Cardiac Ablation |
1.2% |
| Cerebrovascular Accident Prophylaxis |
1.2% |
| Diabetes Mellitus |
1.2% |
| Hypertension |
1.2% |
| Thyroidectomy |
1.2% |
| Blood Pressure |
0.6% |
| Blood Pressure Management |
0.6% |
|
| Photosensitivity Reaction |
10.7% |
| Pulmonary Toxicity |
10.7% |
| Tremor |
10.7% |
| Visual Disturbance |
8.9% |
| Optic Neuritis |
5.4% |
| Pulmonary Fibrosis |
5.4% |
| Respiratory Failure |
5.4% |
| Weight Decreased |
5.4% |
| Weight Increased |
5.4% |
| Alopecia |
3.6% |
| Drug Intolerance |
3.6% |
| Dyspnoea |
3.6% |
| Neoplasm Malignant |
3.6% |
| Somnolence |
3.6% |
| Vaginal Haemorrhage |
3.6% |
| Vomiting |
3.6% |
| Acute Respiratory Distress Syndrome |
1.8% |
| Blindness |
1.8% |
| Constipation |
1.8% |
| Drug Hypersensitivity |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.4% |
| Drug Use For Unknown Indication |
19.1% |
| Atrial Fibrillation |
9.3% |
| Cardiac Disorder |
5.4% |
| Hypertension |
5.1% |
| Diabetes Mellitus |
2.4% |
| Blood Cholesterol Increased |
2.3% |
| Cardiac Failure Congestive |
2.2% |
| Osteoporosis |
2.2% |
| Multiple Myeloma |
1.9% |
| Pain |
1.9% |
| Arrhythmia |
1.7% |
| Prophylaxis |
1.6% |
| Anticoagulant Therapy |
1.5% |
| Anxiety |
1.5% |
| Type 2 Diabetes Mellitus |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Prostate Cancer Metastatic |
1.1% |
| Blood Pressure |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
|
| Vomiting |
14.0% |
| Weight Increased |
8.9% |
| Weight Decreased |
8.4% |
| Thrombocytopenia |
6.1% |
| Pneumonia |
5.6% |
| Myocardial Infarction |
5.1% |
| Therapeutic Agent Toxicity |
4.7% |
| Wrist Fracture |
4.7% |
| Death |
4.2% |
| Tremor |
4.2% |
| Wheezing |
4.2% |
| Unevaluable Event |
3.7% |
| Upper Respiratory Tract Infection |
3.7% |
| Urinary Tract Infection |
3.7% |
| Ventricular Tachycardia |
3.7% |
| Dyspnoea |
3.3% |
| Stress |
3.3% |
| Cardiac Failure Congestive |
2.8% |
| Dizziness |
2.8% |
| Headache |
2.8% |
|
| Interacting |
| Thrombosis |
25.0% |
| Ventricular Arrhythmia |
25.0% |
| Atrial Fibrillation |
12.5% |
| Kidney Infection |
12.5% |
| Product Used For Unknown Indication |
12.5% |
| Prostate Cancer |
12.5% |
|
| Thyroid Neoplasm |
40.0% |
| Cardiac Failure Congestive |
20.0% |
| Tremor |
20.0% |
| Ventricular Tachycardia |
20.0% |
|
